RUS
Details
| Name | Human Stem Cell Institute |
| Placement specification | common stock |
| Placement type | IPO |
| Subscription type | Public offering |
| Start of placement | 12.11.2009 |
| Status | Completed |
| End of placement | 04.12.2009 |
| Placement amount | 15 000 000 |
| Placement volume, mln. USD | 5 |
| Upper bound, USD | 0.38 |
| Lower bound, USD | 0.31 |
| Offering price, USD | 0.33 |
| Price change from the placement date | 214.20% |
| Trading floor | MICEX |
| Investment banks | ALOR INVEST |
| Capitalisation at the moment of placement, mln. USD | 23 |
| Country of operation | Russia |
| Industry | Biotechnologies and life sciences |
| Offering Memorandum |
Issuer
Artgen Biotech is a Russian public biotech company which is engaged in drug discovery, R&D and marketing of innovative proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy and biopharmaceutics.
Web-site: to the issuer site
Issuer news
-
24.03.2022
Cbonds: ACRA affirms Human Stem Cell Institute at "BB+(RU)" (ACRA national rating scale for the Russian Federation credit rating); outlook stable
-
30.07.2021
Cbonds: Human Stem Cell Institute announces about increased RAS net profit for 6 months of 2021 equal to RUB 60.07 million. Total revenue’s increase is 33.88%
-
06.04.2021
Cbonds: RAS. Human Stem Cell Institute. December 31, 2020: long-term liabilities’ increase is 5.11 % YoY
-
25.03.2021
Cbonds: ACRA assigns "BB+(RU)" (ACRA national rating scale for the Russian Federation credit rating) to Human Stem Cell Institute; outlook stable
-
05.06.2020
Cbonds: Rusgrain Holding’s, Human Stem Cell Institute’s 1 Q 2020 Y RAS results were published
-
22.07.2019
Cbonds: First Collection Bureau’s, ALROSA-Nurba’s, Human Stem Cell Institute’s RAS results were published
Stock details
| Stock | Artgen Biotech |
| Type | common stock |
| Par value, RUB | 0.1 |
| State registration number | 1-01-08902-A |
| ISIN | RU000A0JNAB6 |
| Announced volume | 85 000 000 |
MICEX
Ticker:
ISKJ
Quotation list:
Unlisted stocks
Price dynamics
| MICEX |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Dividends | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||